Adrenergic Beta-2 Agonist Effect in Healthy Subjects Completed Phase Trials for Salbutamol (DB01001)

IndicationStatusPhase
DBCOND0084074 (Adrenergic Beta-2 Agonist Effect in Healthy Subjects)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02925130Beta2-mimetic and Central Nervous SystemBasic Science